Healthcare • Biotechnology
EODHD (TTM) · as of Oct 13, 2026
End-of-day close from stored market data, not a live quote.
Sign in to see your position size
We’ll show you if OTLK is in your portfolio and how much it contributes.
Sign inLoading market dates
No upcoming ex-dividend date announced
No 8-K filings in the last 30 days.
9 top institutions tracked
Sentiment: bullish
Last trade: buy 61 days ago
Red flags: 1
68 filers reported a long position in OTLK for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
| Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC | $7M | 4.4M | +122.5% |
| PERCEPTIVE ADVISORS LLC | $5M | 3.1M | New |
| MARSHALL WACE, LLP | $3.2M | 2M | New |
| BlackRock, Inc. | $2.7M | 1.7M | +249.5% |
| JANE STREET GROUP, LLC | $2.3M | 1.4M | New |
| GEODE CAPITAL MANAGEMENT, LLC | $2M | 1.2M | +106.4% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $1.5M | 968.2K | +622.1% |
| HRT FINANCIAL LP | $1.2M | 784.9K | +1,058.4% |
| VANGUARD FIDUCIARY TRUST CO | $1.1M | 661.7K | +274.8% |
| GILPIN WEALTH MANAGEMENT, LLC | $882.5K | 555K | -7.5% |
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.